Open an account Help & support Register Account summary Log out
Skip Header
Home Stock market news

Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Oxford Biomedica inks service deal with Plowshare Therapies

Thu 16 Jul 2026 14:17

(Sharecast News) - Oxford Biomedica announced on Thursday that it has signed an agreement to provide process development and AAV GMP manufacturing services to Plowshare Therapies, supporting the biotechnology company's gene therapy programme for rare genetic diseases. The FTSE 250 firm said the partnership will use OXB's FDA-approved commercial-scale viral vector manufacturing facility in Durham, North Carolina, and could expand to additional programmes and later-stage manufacturing as Plowshare's pipeline progresses.

It said the agreement highlights continued momentum in OXB's AAV business and the growing importance of its expanded US manufacturing footprint following the acquisition of the Durham facility in October 2025.

OXB said the site has attracted a significant number of new clients, reinforcing demand for its end-to-end viral vector development and manufacturing capabilities.

At 0946 BST, shares in Oxford Biomedica were down 0.95% at 636.87p.

Reporting by Josh White for Sharecast.com.

See latest RNS on Investegate

Share this article

Related Sharecast Articles

Wed 19 Aug 2026 14:30
Oakley Capital Investments acquires enterprise AI data platform Graphwise
(Sharecast News) - London-listed Oakley Capital Investments announced on Wednesday that one of its funds has acquired knowledge graph and semantic data technology firm Graphwise.
Wed 19 Aug 2026 13:48
Thursday preview: Walmart, Hays, JD Sports results due
(Sharecast News) - On Thursday, UK corporate releases will include full-year results from recruiter Hays and a trading statement from sportswear retailer JD Sports.
Wed 19 Aug 2026 11:46
DiscoverIE expands manufacturing capacity in India
(Sharecast News) - DiscoverIE Group announced a "major expansion" of its manufacturing capacity in India on Wednesday, opening a new facility in Bangalore to meet growing domestic and international demand.
Wed 19 Aug 2026 11:17
Pinewood Technologies to be taken over by Ridgeview in £545m deal
(Sharecast News) - Software company Pinewood Technologies said on Wednesday that it has agreed to be taken over by technology investor Ridgeview Partners in a £545m deal.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Awards

Award 1
Award 2
Award 3

Policies and important information

Accessibility | Conflicts of interest statement | Consumer Duty Target Market | Consumer Duty Value Assessment Statement | Cookie policy | Diversity, Equity & Inclusion | Diversity, Equity & Inclusion Reports | Doing Business with Fidelity | Investing in Fidelity funds | Legal information | Modern slavery | Mutual respect policy | Privacy statement | Remuneration policy | Statutory and Regulatory disclosures | Whistleblowing programme

Please remember that past performance is not necessarily a guide to future performance, the performance of investments is not guaranteed, and the value of your investments can go down as well as up, so you may get back less than you invest. When investments have particular tax features, these will depend on your personal circumstances and tax rules may change in the future. This website does not contain any personal recommendations for a particular course of action, service or product. You should regularly review your investment objectives and choices and, if you are unsure whether an investment is suitable for you, you should contact an authorised financial adviser. Before opening an account, please read the ‘Doing Business with Fidelity’ document which incorporates our client terms. Prior to investing into a fund, please read the relevant key information document or Product Summary document which contains important information about the fund.

This website is issued by Financial Administration Services Limited, which is authorised and regulated by the Financial Conduct Authority (FCA) (FCA Register number 122169) and registered in England and Wales under company number 1629709 whose registered address is Beech Gate, Millfield Lane, Lower Kingswood, Tadworth, Surrey, KT20 6RP.

© FIL Limited 2026